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Elongation factor Tu is a 
multifunctional and processed 
moonlighting protein
Michael Widjaja1, Kate Louise Harvey1, Lisa Hagemann2, Iain James Berry  1, Veronica Maria 
Jarocki1, Benjamin Bernard Armando Raymond1, Jessica Leigh Tacchi1, Anne Gründel2, Joel 
Ricky Steele  1, Matthew Paul Padula3, Ian George Charles4, Roger Dumke2 & Steven Philip 
Djordjevic1,3
Many bacterial moonlighting proteins were originally described in medically, agriculturally, and 
commercially important members of the low G + C Firmicutes. We show Elongation factor Tu (Ef-Tu) 
moonlights on the surface of the human pathogens Staphylococcus aureus (SaEf-Tu) and Mycoplasma 
pneumoniae (MpnEf-Tu), and the porcine pathogen Mycoplasma hyopneumoniae (MhpEf-Tu). Ef-Tu is 
also a target of multiple processing events on the cell surface and these were characterised using an 
N-terminomics pipeline. Recombinant MpnEf-Tu bound strongly to a diverse range of host molecules, and 
when bound to plasminogen, was able to convert plasminogen to plasmin in the presence of plasminogen 
activators. Fragments of Ef-Tu retain binding capabilities to host proteins. Bioinformatics and structural 
modelling studies indicate that the accumulation of positively charged amino acids in short linear motifs 
(SLiMs), and protein processing promote multifunctional behaviour. Codon bias engendered by an A + T 
rich genome may influence how positively-charged residues accumulate in SLiMs.
Elongation factor Thermo unstable (Ef-Tu) is one the most abundant proteins in bacteria1, 2. It functions as an 
essential and universally conserved GTPase that ensures translational accuracy by catalysing the reaction that 
adds the correct amino acid to a growing nascent polypeptide chain3. After the incoming aminoacyl-tRNA 
docks with the mRNA, GTPase activity induces a conformational change releasing Ef-Tu from the ribosome3–5. 
In Escherichia coli, Ef-Tu is comprised of three functional domains known as domain I (amino acids 1–200), 
domain II (amino acids 209–299) and domain III (amino acids 301–393)6. Domain I forms a helix structure with 
Rossmann fold topology, a structural motif found in proteins that bind nucleotides, while domains II and III are 
largely comprised of beta sheets3, 7. The GTP/GDP binding domains are housed in domain I, while domains I and 
II are needed for nucleotide exchange. Domains II and III physically adjust to form an amino acid tRNA binding 
site3, 5. Ef-Tu sequences derived from phylogenetically diverse species share considerable sequence identity and 
have been used to generate phylogenetic descriptions of the tree of life8. In eukaryotes, domain III also has a role 
in actin polymerisation via an actin-bundling domain9, 10.
Despite its highly conserved function in protein synthesis, non-canonical functions have been described for 
Ef-Tu in all kingdoms of life. Ef-Tu lacks a signal secretion motif yet the ability to execute moonlighting functions 
often requires the molecule to localise to the cell surface. Ef-Tu is a multifunctional protein in higher order eukar-
yotes11–16, parasites17–20, fungi21 and it is has been identified on the surface of a wide range of Gram positive and 
Gram negative pathogenic and commensal bacteria that associate with metazoan species2, 22–29. Bacterial Ef-Tu 
interacts with nucleolin30, 31, fibrinogen and factor H23, 26, plasminogen and several complement factors26, 27, 32, 
laminin33, CD2134, fibronectin2, 33, 35, 36, is immunogenic37 and adheres to the surface of Hep-2 cells33 underscor-
ing the multifunctional adhesive characteristics that have been assigned to this molecule. Ef-Tu binds sulfated 
carbohydrate moieties found on glycolipids and sulfomucin and promotes the binding of Lactobacillus reuteri to 
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mucosal surfaces indicating that Ef-Tu can interact with carbohydrates38. Notably, antibodies against Ef-Tu are 
induced during infections caused by Staphylococcus aureus39, 40 Mycoplasma capricolum41, Mycoplasma ovipneu-
moniae37, Chlamydia trachomatis42, Burkholderia pseudomallei43 and Mycoplasma hyopneumoniae44. Ef-Tu has 
been identified in six surfacome studies (excludes cell membrane and envelope isolations)45–50 performed on S. 
aureus and Ef-Tu is one of twelve proteins consistently identified in the exoproteome of S. aureus from patients 
with bacteraemia51. The major staphylococcal autolysin Alt is implicated in playing a role in secreting cytosolic 
proteins including Ef-Tu into the extracellular milieu24. Moonlighting proteins are likely to be exported via sev-
eral mechanisms including within secreted extracellular vesicles52, during cell lysis53 and via association with 
proteins that are secreted by the Sec machinery54.
The ability of Ef-Tu to be secreted onto the cell surface occurred early in the evolutionary interplay between 
plant pathogenic bacteria and their eukaryote hosts and is a well described pathogen associated molecular pattern 
(PAMP) molecule55, 56. Plants have evolved pattern recognition receptors (PRR) in their cell membranes that are 
designed specifically to recognise PAMP molecules released by bacterial and fungal pathogens56–62. An Ef-Tu 
receptor (EFR) found within Brassica lineages63, 64 recognises the highly conserved N-terminal 18 amino acids 
(elf18) in the native Ef-Tu molecule56, 63, 64. Binding triggers signal transduction events in plant roots that ensure 
that pathogenic bacteria are either contained within callose deposits, destroyed by cellular apoptosis, or succumb 
to an oxidative burst elicited by the production of hydrogen peroxide63. A region spanning surface exposed amino 
acids 176–225, in Ef-Tu from the Gram-negative bacterial pathogen Acidovorax avenae, interacts with a different 
PRR in monocotyledonous plants (see Fig. 1)65. EFR has been transferred from the Brassica species Arabidopsis 
thaliana into the monocot species, rice and transgenic rice plants display enhanced innate immune responses 
when exposed to elf18 from Xanthomonas oryza, a major rice pathogen66. These studies show that plants have 
evolved sophisticated molecular machinery to identify Ef-Tu that is released onto the cell surface by diverse plant 
pathogenic bacteria.
Protein cleavage is emerging as an important post-translational modification that can expand protein func-
tion67–70. This is evident in the genome reduced Mollicutes where species specific Mycoplasmal adhesins and 
lipoproteins are targets of complex processing events67, 71–86. Cleavage fragments are retained on the bacterial cell 
surface and function as adhesins that bind heparin-like glycosaminoglycans67, 73–75, 77, 79, 80, fibronectin67, 76, 78, 84 
and circulatory molecules such a plasmin(ogen) that regulate the fibrinolytic system67, 76, 78, 79, 81. Cleavage motifs 
have been chemically defined in M. hyopneumoniae using mass spectrometry and occur at phenylalanine residues 
in the motif S/T-X-F↓-X-D/E, within stretches of hydrophobic amino acids, and at trypsin-like sites in diverse 
molecules including adhesins, lipoproteins and in metabolic enzymes that traffic to the cell surface77, 79, 82, 83, 85. 
Cleavage fragments are known to be further processed by aminopeptidases83, 85 that also localise on the cell sur-
face87, 88. We propose that protein processing represents another layer by which proteins can expand and modify 
protein function and is under recognised as a post-translational modification in prokaryotes.
In this study we identified Ef-Tu, and an extensive repertoire of processed cleavage fragments of Ef-Tu, on the 
surface of human pathogens S. aureus and Mycoplasma pneumoniae, and the porcine pathogen M. hyopneumo-
niae. Protein cleavage events were mapped using a systems wide dimethyl labelling protocol that allows for the 
identification of modified N-terminal peptides (neo-N-termini) by liquid chromatography tandem mass spec-
trometry (LC-MS/MS) and enabled us to determine how Ef-Tu is processed and presented on the cell surfaces of 
these pathogens. We further characterised the non-canonical functions of Ef-Tu from M. pneumoniae (MpnEf-Tu) 
and show that it is a multifunctional protein that can not only bind to and activate plasminogen in the presence of 
host activators, but is also capable of binding to structurally and chemically diverse host molecules.
Results
Bioinformatic analysis of MhpEf-Tu, SaEf-Tu and MpnEf-Tu. The amino acid sequences of Ef-Tu from M. 
pneumoniae (MpnEf-Tu), M. hyopneumoniae (MhpEf-Tu), and S. aureus (SaEf-Tu) share 60.7% sequence identity. 
MpnEf-Tu resides on the cell surface of M. pneumoniae and binds fibronectin2. The fibronectin-binding regions 
have been mapped and are located at the end of domain I and at the beginning of domain II89, 90 and most of 
domain III is also involved in binding fibronectin89. It is not known if sequence conservation in fibronectin-bind-
ing regions of MhpEf-Tu and SaEf-Tu is sufficient to afford these Ef-Tu homologs the ability to bind fibronectin. 
Several Mycoplasma species73, 91 and S. aureus92–94 are known to interact with heparin. Putative heparin-binding 
domains were computationally predicted and mapped onto each of the Ef-Tu molecules (Fig. 1). Several of these 
were conserved in all three Ef-Tu sequences in domains I, II and III.
MhpEf-Tu, SaEf-Tu and MpnEf-Tu are accessible on the bacterial surface and are retained during 
heparin-agarose chromatography. LC-MS/MS analysis of tryptic peptides released from the cell surface 
of S. aureus, M. pneumoniae and M. hyopneumoniae were separately mapped to SaEf-Tu, MpnEf-Tu and MhpEf-Tu 
respectively. In other experiments, tryptic peptides generated by digesting biotinylated cell surface proteins that 
were captured by avidin agarose chromatography were also separately mapped to SaEf-Tu, MpnEf-Tu and MhpEf-Tu. 
Peptides identified by mass spectrometry from both techniques spanned the entire length of Ef-Tu, (Figure S1) 
consistent with the hypothesis that a sub-population of Ef-Tu molecules are exposed on the cell surface of the 
three pathogens (Fig. 2) while the remainder perform an essential function in the cytosol. Tryptic peptides span-
ning the length of SaEf-Tu, MpnEf-Tu and MhpEf-Tu were also characterised when LC-MS/MS analysis was performed 
on tryptic digests of high salt (>500 mM) eluents of proteins that were retained on heparin agarose (Fig. 2).
MhpEf-Tu, SaEf-Tu and MpnEf-Tu are cleaved on the bacterial cell surface. As part of a larger study that 
sought to identify the repertoire of proteins in M. pneumoniae, M. hyopneumoniae and S. aureus that are targets of 
proteolytic processing events, we employed a dimethyl labelling protocol to tag N-terminal peptides and identify 
precise endoproteolytic cleavage sites (Table 1). Further evidence that SaEf-Tu, MpnEf-Tu and MhpEf-Tu are targets 
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Figure 1. Bioinformatic analysis of MpnEf-Tu, MhpEf-Tu, and SaEf-Tu. (a) Schematic of MpnEf-Tu, MhpEf-Tu, and 
SaEf-Tu highlighting putative heparin and fibronectin-binding domains and cleavage sites. ScanProsite144 was 
used to predict heparin-binding motifs (dark blue boxes) by searching clusters of basic residues with the 
“X-[HRK]-X(0,2)-[HRK]-X(0,2)-[HRK]-X” and “X-[HRK]-X(1,4)-[HRK]-X(1,4)-[HRK]-X” motifs. A putative 
transmembrane domain (score 505) was predicted in MhpEf-Tu using TMpred142 (yellow box). In MpnEf-Tu, two 
fibronectin-binding regions (salmon boxes) and two predicted transmembrane domains (scores) are depicted 
in Panels a and b89, 90. Key amino acids in MpnEf-Tu involved in binding fibronectin89, 90 are underlined. Cleavage 
sites identified in this study are shown as arrows above the black bar (blue indicates cleavage sites identified by 
dimethyl labelling and red indicates cleavage sites identified by the characterisation of semi-tryptic peptides by 
LC-MS/MS). (b) Amino acid sequence alignments of MpnEf-Tu, MhpEf-Tu, and SaEf-Tu. For consistency, features 
described in Fig. 1a are represented by the same colour scheme in Fig. 1b. Cleavage sites identified in this 
study are depicted by the symbol Ζ. Sequence alignments have been separated into the three domains and the 
nucleotide-binding motifs (boxed regions) and the two pattern recognition receptors (broken black outline grey 
box from Acidovorax avenae65 and Brassica-specific receptors64) are shown.
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Figure 2. Binding to heparin by Ef-Tu and cleavage fragments of Ef-Tu. Panel a–c show MpnEf-Tu, MhpEf-Tu, 
and SaEf-Tu, and surface accessible cleavage fragments of these molecules retained during heparin-agarose 
chromatography respectively. Peptides identified (black boxes within coloured bars) by mass spectrometry 
within Ef-Tu fragments were obtained from 1D and 2D SDS-PAGE of bacterial whole cell lysates (grey bars), 
avidin affinity chromatography of biotinylated surface proteins (red bars), and heparin-agarose affinity 
chromatography (blue bars). Full length Ef-Tu molecules are represented as black bars. Cleavage products of 
Ef-Tu are also shown. Cleavage sites were identified by identifying dimethyl labelled peptides (blue arrows 
and broken lines) and by characterising semi-tryptic peptides generated after trypsin digestion (red arrows 
and broken lines). Exact cleavage sites are shown in the amino acid sequences above the black bar. For M. 
pneumoniae, the two fibronectin-binding regions (salmon boxes, Fn) and two putative transmembrane domains 
described by89, 90 were included. Bioinformatic tools such as ScanProsite144, TMpred142, COILS143 and Meta-
Disorder145 were used to predict putative heparin-binding motifs (Hep, blue boxes), transmembrane domains 
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of protein cleavage events was obtained by LC-MS/MS analysis of i) SDS-PAGE gel slices separately loaded with 
biotinylated M. pneumoniae, M. hyopneumoniae and S. aureus surface proteins captured by avidin chromatog-
raphy, ii) bacterial proteins that eluted from heparin agarose using high salt (>500 mM NaCl), iii) protein spots 
representing bacterial whole cell lysates and surface biotinylated proteins separated by 2D-PAGE, and iv) size 
fractioned whole cell lysate proteins resolved by SDS-PAGE.
Of the 15 cleavage fragments of MpnEf-Tu identified in this study, 11 were identified in the biotinylated 1D 
and 2D SDS-PAGE. Notably, three of the four cleavage fragments derived from MhpEf-Tu and two of six frag-
ments of SaEf-Tu that were enriched during heparin affinity chromatography were also identified in biotinylation 
experiments (Figures S4, S5 and S6). Ten, four and six cleavage fragments that span different regions of MpnEf-Tu, 
MhpEf-Tu and SaEf-Tu respectively were recovered from a heparin agarose chromatography using salt concentra-
tions well above the physiological concentration of 150 mM. All the fragments recovered from heparin affinity 
chromatography across all three pathogens contained at least one of the predicted heparin-binding domains that 
reside within MpnEf-Tu, MhpEf-Tu and SaEf-Tu. These data suggest that the processing events that generate Ef-Tu 
cleavage fragments, occur on the surface of each of these pathogens and that the fragments may retain an ability 
to interact with high sulfated glycosaminoglycans such as heparin. To ascertain the nature of the protease(s) 
responsible for Ef-Tu surface cleavage, the MEROPs database was used to search 56 cleavage events. However, no 
strong predictions could be made after searching both P4-P3-P2-P1↓P1′-P2′-P3′-P4′ and P2-P1↓P1′-P2′ cleavage 
motifs.
Processing events expose new predicted surface macromolecule interaction sites. A single 
heparin-binding consensus motif (XBBBXXBX, where B is a basic residue) with the sequence DKRHYAHV is 
found within the amino acid sequences of SaEf-Tu, MpnEf-Tu, and MhpEf-Tu, yet we found several Ef-Tu fragments 
that were retained during heparin agarose chromatography that did not span this motif. SaEf-Tu, MpnEf-Tu, and 
MhpEf-Tu sequences were examined for additional motifs enriched with clustered basic residues. In MpnEf-Tu we 
identified 12 putative heparin-binding motifs dispersed throughout the protein (Table S1). Many of these puta-
tive heparin-binding motifs, particularly sequences 37aKegKsaatRy47, 183pKweaKiHd191 and 248lRpiRKa254 were 
localised to non-essential regions defined here as evolutionary unconserved regions (See S9 - Supplementary 
Materials: Bioinformatics and Table S1). Using ISIS95, which predicts protein-protein interaction (PPI) sites 
from sequence information, MpnEf-Tu is predicted to have eight surface exposed PPI sites that are capable of 
binding macromolecules (Table S2A) such as glycosaminoglycans including four that reside within putative 
heparin-binding motifs 2aReKfdRsKpHv13, 73dKRHyaHv80 and 370eKgsKfsiReggRt383 (Table S1). Notably, the 
key residues (underlined and in bold) in the four binding sites were all unconserved residues as determined by 
ConSurf96. Putative heparin-binding fragments derived from MpnEf-Tu typically displayed more putative PPI sites 
and were more intrinsically disordered than the parent molecule and some fragments displayed putative nucleic 
acid interaction sites (Fig. 2), which are absent in the unprocessed, parent molecule. Additionally, three short 
linear motifs located in unconserved regions of Ef-Tu that were not predicted binding sites in the parent molecule 
were predicted to be exposed in MpnEf-Tu fragment 3 (37aKegKsaatRy47), fragment 4 (183pKweaKiHd191), fragment 
5 (37aKegKsaatRy47), fragment 6 (248lRpiRKa254), fragment 7 (37aKegKsaatRy47 and 183pKweaKiHd191), fragment 
10 (183pKweaKiHd191), fragment 12 (183pKweaKiHd191) and fragment 13 (248lRpiRKa254) (Table S1).
Molecular modelling of Ef-Tu. The prediction tool MODELLER97 was used to predict the structures of 
Ef-Tu for all three pathogens based on Ef-Tu from E. coli. For the M. pneumoniae prediction, the E. coli Ef-Tu 
(PDB: 4G5G_A) had a structure ID percentage of 70.5% and a zDOPE score of −0.93. For M. hyopneumoniae, the 
E. coli Ef-Tu (PDB: 1DG1_H) had a structure ID percentage of 68.6% and a zDOPE score of −0.72. For S. aureus, 
the E. coli Ef-Tu (PDB: 1DG1_H) had a structure ID percentage of 75.1% and a zDOPE score of −0.88. All nine 
distinct cleavage sites for M. pneumoniae and S. aureus and four sites for M. hyopneumoniae have all been mapped 
in the ribbon structures (Figure S2). Cleavage sites located in regions that are predicted to release the three 
domains are mostly surface accessible within the molecule. The location and accessibility of the heparin-binding 
domains in MpnEf-Tu, MhpEf-Tu and SaEf-Tu and the two published fibronectin-binding domains in MpnEf-Tu are 
depicted in Figure S3.
MpnEf-Tu and MhpEf-Tu are potential multifunctional binding proteins. It was notable that MpnEf-Tu 
was recovered from M. pneumoniae native cell lysates that were loaded onto affinity columns coupled with A549 
epithelial cell surface proteins, fetuin, fibronectin, actin or plasminogen (Figure S4). Consistent with these data, 
rMpnEf-Tu bound to immobilized A594 cells in microtitre plate binding assays (Fig. 3a). Proteins that bind (recom-
binant pyruvate dehydrogenase subunit B) and that do not bind (P08 fragment of P1 adhesin) to A594 cells were 
used positive and negative controls respectively98. Binding of rMpnEf-Tu to A594 cells was partially inhibited when 
anti-rMpnEf-Tu antibodies, but not pre-immune antiserum, was present (Fig. 3b). MhpEf-Tu was recovered from 
(TmD, yellow box for M. hyopneumoniae), coiled-coils (Coil, orange boxes), and disordered regions (purple 
boxes in grey bar), respectively. Peptides released from trypsin shaving of cells are shown as the green boxes in 
the grey bar. Circles just above fragments denote amino acid positions that are predicted to be surface exposed 
and represent putative protein-protein interaction regions (visual cues can be seen on the right of the cleavage 
map, sites listed in Tables S2A, S2B, and S2C). Those marked with an additional star denote amino acid residues 
that fall within predicted putative heparin-binding domains. White circles mark evolutionary unconserved 
binding regions, whilst yellow circles are mildly conserved and pink are highly conserved. Amino acid positions 
marked by grey triangles depict predicted nucleic acid interaction regions.
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No. ID Peptide Sequence Score E-value
Dimethyl Labelled peptides from MpnEf-Tu
1
N1 K.58ARGITINSAHVEYSSDKR75.H 41 3.00E−03
N2 R.60GITINSAHVEYSSDKR75.H 94 1.20E−08
3 N3 R.131MVVFLNK137.C 57 1.30E−03
5
N4 Q.242EIEIVGLRPIR252.K 48 3.30E−03
N5 E.243IEIVGLRPIR252.K 35 0.033
N6 I.244EIVGLRPIR252.K 37 0.014
7
N7 K.305FKAEIYALKKEEGGR319.H 110 9.40E−09
N8 K.307AEIYALKKEEGGR319.H 69 2.60E−05
8
N9 R.320HTGFLNGYRPQFYFR334.T 61 2.80E−05
N10 H.321TGFLNGYRPQFYFR334.T 39 2.90E−03
N11 N.326GYRPQFYFR334.T 43 1.70E−03
Semi-tryptic C-terminal Peptides from MpnEf-Tu
6
S1 R.253KAVVTGIEMFKKELD267.S 47 4.50E−04
S2 R.253KAVVTGIEMFKKELDS268.A 56 4.50E−05
S3 R.253KAVVTGIEMFKKELDSAMA273.G 55 7.30E−05
S4 R.253KAVVTGIEMFKKELDSAMAG272.D 95 4.50E−09
S5 R.253KAVVTGIEMFKKELDSAMAGDNA275.G 96 3.30E−09
S6 R.253KAVVTGIEMFKKELDSAMAGDNAG276.V 113 2.90E−09
S7 R.253KAVVTGIEMFKKELDSAMAGDNAGVLL279.R 55 2.00E−05
7
S8 R.290GQVLAKPGSIKPHKKF305.K 46 1.50E−04
S9 R.290GQVLAKPGSIKPHKKFKA307.E 61 2.10E−06
S10 R.290GQVLAKPGSIKPHKKFKAE308.I 27* 4.40E−03
S11 R.290GQVLAKPGSIKPHKKFKAEIY310.A 38 2.40E−03
8
S12 R.290GQVLAKPGSIKPHKKFKAEIYALKKEEGG318.R 85 7.00E−08
S13 R.290GQVLAKPGSIKPHKKFKAEIYALKKEEGGRH320.T 24 8.20E−03
S14 R.290GQVLAKPGSIKPHKKFKAEIYALKKEEGGRHT321.G 15* 0.048
S15 R.290GQVLAKPGSIKPHKKFKAEIYALKKEEGGRHTG322.F 48 3.00E−04
S16 R.290GQVLAKPGSIKPHKKFKAEIYALKKEEGGRHTGFLN325.G 25* 9.50E−03
S17 R.320HTGFLNG326.Y 21* 0.058
Semi-tryptic N-terminal Peptides from MpnEf-Tu
1 S18 I.62TINSAHVEYSSDKR75.H 37 4.60E−03
2 S19 D.111SVMPQTREHILLAR124.Q 65 7.00E−05
4 S20 D.218TMTITGR224.G 41 0.041
6
S21 L.267DSAMAGDNAGVLLR280.G 73 2.40E−06
S22 D.268SAMAGDNAGVLLR280.G 85 3.60E−06
S23 S.269AMAGDNAGVLLR280.G 58 1.30E−03
S24 A.270MAGDNAGVLLR280.G 53 7.20E−04
S25 M.271AGDNAGVLLR280.G 75 1.90E−05
S26 A.272GDNAGVLLR280.G 59 7.70E−04
S27 G.273DNAGVLLR280.G 57 1.30E−03
S28 D.274NAGVLLR280.G 42 0.031
8
S29 H.321TGFLNGYRPQFYFR334.T 76 6.00E−06
S30 T.322GFLNGYRPQFYFR334.T 47 3.00E−03
S31 G.323FLNGYRPQFYFR334.T 77 3.00E−05
S32 L.325NGYRPQFYFR334.T 62 5.30E−05
S33 N.326GYRPQFYFR334.T 47 2.90E−04
S34 G.327YRPQFYFR334.T 59 1.40E−03
9
S35 C.370EKGSKFSIR378.E 66 1.30E−03
S36 C.370EKGSKFSIREGGR382.T 35 6.60E−03
Dimethyl Labelled peptides from MhpEf-Tu
1
N1 M.2AVVKTTGKKDFR14.S 84 5.70E−07
N2 A.3VVKTTGKKDFR14.S 36 0.021
N3 V.4VKTTGKKDFR14.S 34 0.019
2 N4 V.112VAATDGPMPQTR123.E 74 1.70E−05
4 N5 A.316AIYALKKEEGGR327.H 50.1 3.00E−05
Semi-tryptic N-terminal Peptides from MhpEf-Tu
Continued
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native cell lysates of M. hyopneumoniae that were loaded onto affinity columns coupled with PK15 epithelial 
cell surface proteins, fibronectin, actin, or plasminogen (Figure S4). MpnEf-Tu has previously been shown to bind 
fibronectin2 and we independently confirmed this in microtitre plate binding assays. Furthermore, our binding 
assay suggests that M. pneumoniae encodes fibronectin-binding proteins other than Ef-Tu (Fig. 4). MpnEf-Tu, and 
nine of the fifteen cleavage fragments of MpnEf-Tu, were recovered from affinity columns loaded with fibronectin 
(Figure S3). Of the nine cleavage fragments, seven spanned the known fibronectin-binding regions described 
previously (see Fig. 1)89, 90. We also identified fragments from columns coupled to fibronectin that spanned 
the N-terminus of MpnEf-Tu suggesting that other fibronectin-binding domains are yet to be identified in this 
No. ID Peptide Sequence Score E-value
3 S1 M.215DKPFLMAVEDVFTITGR231.G 68 2.50E−05
Dimethyl Labelled peptides from SaEf-Tu
2
N1 D.101GGILVVSAADGPMPQTR117.E 98 2.90E−05
N2 G.103ILVVSAADGPMPQTR117.E 81 1.30E−03
N3 I.104LVVSAADGPMPQTR117.E 104 5.90E−06
N4 L.105VVSAADGPMPQTR117.E 91 1.10E−04
N5 V.107SAADGPMPQTR117.E 69 9.90E−03
3
N6 N.137KVDMVDDEELLELVEMEVR155.D 80 3.10E−03
N7 D.140MVDDEELLELVEMEVR155.D 78 3.40E−03
4
N8 L.191ELMEAVDTYIPTPER205.D 78 3.60E−03
N9 E.192LMEAVDTYIPTPER205.D 78 3.20E−03
N10 L.193MEAVDTYIPTPER205.D 72 2.80E−03
N11 M.194EAVDTYIPTPER205.D 103 8.40E−06
N12 E.195AVDTYIPTPER205.D 77 9.60E−04
7
N13 K.265LLDYAEAGDNIGALLR280.G 98 4.10E−05
N14 L.267DYAEAGDNIGALLR280.G 88 1.80E−04
N15 D.268YAEAGDNIGALLR280.G 89 2.40E−04
N16 G.273DNIGALLR280.G 67 1.80E−02
9 N17 R.335TTDVTGVVHLPEGTEMVMPGDNVEMTVELIAPIAIEDGTR374.F 86 7.70E−07
Semi-tryptic N-terminal Peptides from SaEf-Tu
8 S1 V.293LAAPGSITPHTEFK306.A 106 3.20E−05
5 S2 M.214PVEDVFSITGR224.G 80 0.010
1 S3 N.15IGTIGHVDHGK28.T 80 1.10E−04
6 S4 F.263RKLLDYAEAGDNIGALLR280.G 91 1.20E−03
Table 1. Dimethyl labelled and semi-tryptic peptides identified in MpnEf-Tu, MhpEf-Tu and SaEf-Tu. Identified 
peptides have a Mascot score >33 and an E-value <0.05 unless marked with a *. Peptides marked with a *implies 
the peptide score was <33 but still lies within major cleavage site. The exact site of cleavage is to the left of the 
amino acid that is bold and underlined for N-terminal cleavage fragments and to the right of C-terminal cleavage 
fragments. Amino acid numbers are written at the start and end of each peptide identified by LC-MS/MS.
Figure 3. Binding of rMpnEf-Tu to human A549 epithelial cells. (a) A549 cells (‘with cells’) were bound to wells 
of a 96-well mictrotitre plate and incubated with rEf-Tu. Bound rMpnEf-Tu was detected with antisera raised 
against rMpnEf-Tu. rPdhB and rP08 were used as a positive and negative control98, respectively. Bars represent 
standard deviation of eight replicates. (b) rMpnEf-Tu was incubated with either antisera raised against rMpnEf-Tu 
or pre-immune sera (PIS) and added to A549 cells in ELISA plates. rPdhB and rP08 and the corresponding 
antisera were used as a positive and negative control98, respectively. Bars represent standard deviation of eight 
replicates.
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molecule. MhpEf-Tu and six cleavage fragments of MhpEf-Tu were retained by columns coupled with fibronectin 
(Figure S5). The cleavage fragments spanned the N- and C-terminal ends, as well as the central region of MhpEf-Tu 
suggesting that it may contain fibronectin-binding domains.
Ten fragments spanning different regions of MpnEf-Tu (Figure S4) and one MhpEf-Tu fragment (Figure S5) were 
identified from affinity columns coupled with biotinylated surface proteins derived from A549 and PK-15 cells, 
respectively. MpnEf-Tu and MhpEf-Tu, and fragments derived from them, were recovered from actin-coupled col-
umns (Figures S4 and S5). Five fragments of MpnEf-Tu were recovered during affinity chromatography using fetuin 
as bait (Figure S4).
M. pneumoniae99–101 and M. hyopneumoniae78, 81 have both been shown to bind plasminogen onto their cell 
surface and assist with its conversion to plasmin. In the current study, MpnEf-Tu and MhpEf-Tu were both recovered 
during plasminogen agarose chromatography. Fragments spanning different regions of MpnEf-Tu (Figure S4) and 
MhpEf-Tu (Figure S5) were recovered from plasminogen coupled agarose beads.
MpnEf-Tu is a multifunctional adhesin. Antibodies raised against rMpnEf-Tu were used to show that 
MpnEf-Tu resides on the surface of colonies of M. pneumoniae (Figure S7). Our surfaceome studies (unpublished 
data) identified candidate proteins that could be used as a negative control for these studies and antibodies raised 
against recombinant 1-phosphofructokinase (FruK) from M. pneumoniae were used for this purpose (Figure S7). 
To further investigate the binding capabilities of rMpnEf-Tu, we examined the ability of the molecule to interact 
with a range of host molecules. rMpnEf-Tu bound to fetuin (KD = 53 ± 14 nM), actin (KD = 19 ± 3 nM) and heparin 
(KD = 42.5 ± 1.5 nM) in the nanomolar range and to plasminogen (KD = 933 ± 388 nM) in the micromolar range, 
using microscale thermophoresis (Figure S8). We extended these studies using microtitre plate binding assays to 
confirm that rMpnEf-Tu binds plasminogen and fibronectin, and also show that rMpnEf-Tu binds fibrinogen, vit-
ronectin, lactoferrin and laminin in a dose dependent manner (Fig. 4). Binding of rMpnEf-Tu to plasminogen was 
significantly reduced by the addition of an increasing concentration of NaCl and ε-aminocaproic acid (Fig. 5a). 
Notably, ε-aminocaproic acid was effective at blocking interactions between M. pneumoniae and plasminogen 
while high concentrations of NaCl were less effective (Fig. 5a). These data suggest that lysine residues play a sig-
nificant role in binding interactions between Ef-Tu and plasminogen, and M. pneumoniae cells and plasminogen.
In the presence of plasminogen activators tPA and uPA plasminogen bound to rMpnEf-Tu is converted to plas-
min and can degrade fibrinogen and vitronectin (Fig. 5b). Collectively these studies highlight the widespread 
multifunctional capabilities of Ef-Tu and the cleavage fragments derived from it.
Discussion
Ef-Tu moonlights on the cell surface of S. aureus, M. pneumoniae and M. hyopneumoniae, three phylogenet-
ically diverse, pathogenic bacteria that belong to the low G + C Firmicutes. Using a combination of micros-
cale thermophoresis and microtitre plate binding assays we show that rMpnEf-Tu binds strongly to heparin 
(KD = 42.5 ± 1.5 nM), fetuin (KD = 53 ± 14 nM) and actin (KD = 19 ± 3 nM), as well as to laminin, plasminogen, 
Figure 4. Microtitre plate binding assays depicting the interaction of rMpnEf-Tu with human proteins. Wells 
of microtitre plates were coated with rMpnEf-Tu and incubated with increasing concentrations of host proteins. 
Antisera against each of the host proteins was used to detect interaction with rMpnEf-Tu. M. pneumoniae cells 
and BSA were used as a positive and negative control, respectively. Bars represent standard deviation of eight 
replicates.
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vitronectin, lactoferrin, fibronectin, and fibrinogen. Plasminogen bound to rMpnEf-Tu can be converted to plasmin 
in the presence of plasminogen activators tPA and uPA (Fig. 5). We also extend these finding by showing that 
SaEf-Tu, MpnEf-Tu and MhpEf-Tu are targets of processing events on the cell surface of these bacterial pathogens but 
the biological significance of this warrants further investigation (see below). Molecules are not strictly confined 
to compartments in the bacterial cell and can perform novel functions at different cellular locations24, 25, 54, 102–105. 
Much remains to be learnt about how proteins, especially those lacking signal motifs, localise on bacterial cell 
surfaces.
We sought to gain a better understanding of how Ef-Tu has evolved to be a multifunctional binding pro-
tein. SaEf-Tu, MpnEf-Tu and MhpEf-Tu all putatively bind heparin, each sharing the consensus heparin-binding 
motif XBBBXXBX (sequence: dKRHyaHv) as well as a number of other heparin-binding motifs (see Fig. 1 and 
Table S1). It is notable that while this motif (dKRHyaHv) is conserved in the Ef-Tu from M. pneumoniae, M. 
Figure 5. Influence of ions and lysine analog ACA on binding of rMpnEf-Tu to plasminogen and degradation 
of human fibrinogen and vitronectin by activated plasminogen. (a) Microtitre plate wells were coated with 
rMpnEf-Tu and incubated with plasminogen and increasing concentrations of either NaCl (‘ionic interactions’) 
or ε-aminocaproic acid (‘ACA’). Bound plasminogen was detected with anti-plasminogen antibodies. In control 
experiments M. pneumoniae cells were coated onto microtitre plates and incubated with plasminogen and 
increasing concentrations of either NaCl or ACA. Bars represent standard deviation of eight replicates. (b) 
Fibrinogen or vitronectin was mixed with either urinary plasminogen activator (uPA) or tissue plasminogen 
activator (tPA) and added to microtitre plates previously coated with rMpnEf-Tu and plasminogen. Samples were 
separated by SDS-PAGE, blotted onto nitrocellulose membrane and probed with anti-vitronectin and anti-
fibrinogen antisera. Lane 1 is at 0 hours, lane 2 is after over-night incubation without plasminogen, and lane 3 is 
after over-night incubation with plasminogen. Full length blots can be seen in Figure S9.
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hyopneumoniae and S. aureus only part of the motif, with the sequence RHyaHv, is conserved in Ef-Tu from 
other bacterial sources. The addition of DK residues is predicted to impart a putative PPI site. Twelve puta-
tive heparin-binding motifs identified in MpnEf-Tu (Table S1) were predicted to predominantly localise to 
non-essential, unconserved regions of the molecule that do not unduly influence its ability to function as an 
elongation factor. Short linear motifs (SLiMs) typically ranging from three to ten amino acids play crucial roles 
in mediating PPIs106–108. In eukaryotes, these motifs are typically located in intrinsically unstructured, disordered 
regions of proteins that impart plasticity and are reported to favour transient, low affinity and reversible inter-
actions106, 109. Notably, MpnEf-Tu formed strong interactions with fetuin, heparin, and actin suggesting that the 
accumulation of SLiMs may be sufficient to form high affinity interactions.
Positively charged amino acids in SLiMs play a crucial role in interactions between proteins and highly sul-
phated glycosaminoglycans such as heparin110, and other molecules such as actin111, plasminogen112, DNA113, 114 
and fibronectin69, 84, 115. Here we identified SLiMs enriched in positively charged amino acids in different regions 
of MpnEf-Tu, including sequences 37aKegKsaatRy47, 183pKweaKiHd191, and 248lRpiRKa254, and identified eight sur-
face exposed PPI sites, including three that reside within putative heparin-binding motifs 2aReKfdRsKpHv13, 
73dKRHyaHv80, and 370eKgsKfsiReggRt383. It is notable that the lysine analog, ε-amino caproic acid, was shown 
to be a potent inhibitor of interactions between MpnEf-Tu and plasminogen, and M129 whole cells and plasmino-
gen, underscoring the important role played by positively charged amino acids in binding interactions with host 
molecules (Fig. 5a). Overlapping SLiMs are frequently identified in multifunctional proteins106, 116. In M. hyo-
pneumoniae, the C-terminal sequence 1070KKsslKvKitvK1081 in the multifunctional cilium adhesin, P97 binds both 
heparin and fibronectin84 and overlapping peptides from a region within phosphoglycerate kinase from group B 
streptococcus strain NCS13 with sequence 203sKvsdKigvienlleKadKv222 and 213enlleKadKvligggmtytf232 bind both 
actin and plasminogen112. Similarly, we were able to identify SLiMs enriched in positively charged amino acids in 
SaEf-Tu and MhpEf-Tu. The accumulation of positively charged residues in SLiMs, possibly as a consequence of an 
A + T rich genome, facilitates binding to a wide range of host molecules in the low G + C Firmicutes. Our data 
is consistent with the proposition that the accumulation of surface exposed SLiMs represents a mechanism to 
generate protein multifunctionality in bacterial proteins.
S. aureus92 and M. hyopneumoniae73–75, 82, 84, 87, 88, display cell surface, heparin-binding proteins that are impor-
tant to the pathogenic potential of these species. Interactions between heparin-binding proteins and target recep-
tors in host cell membrane allow microbes to colonise a wide range of niche sites, traverse tissue barriers and 
disseminate from their initial point of contact and form biofilms117. S. aureus118, 119, M. pneumoniae120, 121 and M. 
hyopneumoniae (our unpublished data) are all capable of forming biofilms. The extracellular matrix of S. aureus 
biofilms is derived from a mixture of eDNA and cytoplasmic proteins118, 122–127 and electrostatic interactions 
between cytoplasmic proteins and eDNA is thought to tether cells together in S. aureus and mixed species bio-
films127. In S. aureus, the addition of heparin increases biofilm production in a protein dependant manner which 
implies that heparin-binding proteins are important for biofilm development92. Notably, Ef-Tu has been identified 
on the surface of S. aureus under biofilm inducing conditions122. These observations lend weight to the hypothesis 
that the accumulation of positively charged amino acids in SLiMS represents a powerful mechanism to promote 
PPIs that underpin essential biological processes such as the formation and maintenance of biofilms.
Bacterial pathogens including Campylobacter jejuni69, Mycoplasma gallisepticum86, and Chlamydia trachoma-
tis128 process molecules that are secreted to the cell surface. In M. hyopneumoniae, processing of cilium adhesin 
families has been reported extensively and cleavage motifs have been mapped73, 77, 80, 83. Recently we showed 
that lactate dehydrogenase is cleaved on the surface of M. hyopneumoniae generating fragments with putative 
multifunctional binding capabilities68. In M. pneumoniae, cleavage fragments of the major adhesin P1 and DnaK 
have been shown to comprise part of the cytoskeletal attachment organelle complex129 and Mycoplasma derived 
lipoproteins are targets of processing events that release powerful immunomodulatory peptides71, 130–132. These 
observations prompted us to utilise a systems wide, protein dimethyl labelling strategy to investigate protein pro-
cessing. Here we identified and characterised numerous processing sites in Ef-Tu derived from all three bacterial 
pathogens. Furthermore, our surface biotinylation studies indicate MpnEf-Tu, MhpEf-Tu and SaEf-Tu, were a target 
of multiple processing events on the surfaces of M. pneumoniae, M. hyopneumoniae and S. aureus, respectively. 
Our work strongly suggests that the accumulation of positively charged residues in the SLiMs found in Ef-Tu 
facilitates binding to a wide range of host molecules, and potentially to eDNA and that protein cleavage events 
expand the functional complexity of proteins that moonlight on the cell surface. We propose that processing is a 
mechanism that has evolved to promote multifunctional behaviour more broadly and lends itself to the creation 
of novel binding sites in moonlighting proteins that retain a strict conformational structure needed to execute 
their canonical function.
Fifteen cleavage fragments of MpnEf-Tu were identified in this study of which eleven reside on the cell surface. 
Unlike full length MpnEf-Tu, none of the fragments were retained in all six affinity chromatography columns, but 
five were identified in at least five affinity columns (fragments 5, 6, 7, 8, and 10 in Figure S4). Fragments 5, 8, 
and 10 were retained in columns coupled with: A549 surface proteins, fetuin, fibronectin, actin, and heparin. 
Fragments 6 and 7 were retained in columns coupled with: A549 surface proteins, fibronectin, actin, heparin, and 
plasminogen. Fragment 4 was identified in eluents from columns coupled with A549 surface proteins and heparin 
while Fragment 9 was identified in eluents from columns coupled with fetuin and actin (see Figure S4). These data 
indicate that retention of the fragments during affinity chromatography is dependent on the host molecule that is 
coupled to the agarose beads and the sequence of the Ef-Tu fragment. Further studies are needed to quantify the 
binding characteristics of fragments of Ef-Tu with host molecules.
Cleavage fragments of cytosolic proteins that moonlight on the cell surface add another layer of complexity 
to the concept of multifunctional proteins. We show that processing exposes SLiMs that would otherwise be 
inaccessible for interactions with potential binding partners. Recently, a peptidome study of a protease deficient 
strain of Lactococcus lactis identified 1800 distinct peptide fragments in spent growth medium that were derived 
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from proteolytic activity targeting both surface accessible and cytosolically derived proteins133. Similar studies by 
the same group indicated that surface accessible proteins in other Firmicute species including Listeria monocy-
togenes, Enterococcus faecalis and Streptococcus thermophilus were also targeted by complex processing events133. 
Previously we have shown that processing events play an important role in the maturation of key adhesin families 
in pathogenic mycoplasma species67, 72–86. Here we extend these findings to show that surface proteolysis is crit-
ical in shaping the surface proteome more broadly and that processing represents a novel and under recognised 
mechanism to expand protein function.
In summary, Ef-Tu moonlights on the surface of bacteria where it is a target of proteolytic processing events. 
Computational analysis of fragments of MpnEf-Tu suggest they are inherently more disordered and display putative 
PPI sites that are inaccessible in the parent molecule, generating unprecedented functional diversity on the cell 
surface. Further studies, using systems wide methodologies, are needed to determine how processing generates 
biologically important effector molecules and if protein processing is fundamental to the expansion of protein 
function in bacteria belonging to different phylogenetic clades.
Experimental Section
A full description of the experimental section is listed in the S10 - Supplementary Materials 3.
Strains and cultures and reagents. M. pneumoniae (M129 strain; ATCC 29342) was cultured in modified 
Hayflick’s medium at 37 °C in tissue culture flasks as described previously134.
M. hyopneumoniae (J strain) was cultured in modified Friis medium at 37 °C with shaking as described pre-
viously135, 136.
S. aureus (SH 1000 strain) was cultured in TSB (Oxoid, Hampshire, UK) at 37 °C with shaking and harvested 
during early stationary phase. Protease inhibitors (Roche Diagnostics®, North Ryde, Australia) in PBS were 
added to the cells during harvest and washes with PBS. For S. aureus lysis, cell pellets were freeze-dried overnight 
before added to pre-cooled metal milling canisters with 12 small metal beads. The canister was cooled in liquid 
nitrogen and milled at a maximum frequency of 30 Hz for 1 minute for 15 rounds; cooling in liquid nitrogen 
between rounds. Proteins were than solubilised in 7 M urea, 2 M thiourea, 50 mM LiCl, 50 mM Tris-HCl (pH 
8.8), 1% (w/v) C7bZ0 with protease inhibitors followed by sonication at maximum intensity for 30 seconds for 20 
rounds resting on ice in between.
Human lung carcinoma cells (A549; ATCC CCL-185) were cultured in RPMI 1640 medium (Invitrogen, 
Carlsbad, CA) supplemented with 10% heat inactivated fetal bovine serum at 37 °C with 5% CO2 in tissue culture 
flasks.
Porcine kidney epithelial (PK-15) cells were cultured in DMEM medium (Invitrogen) supplemented with 10% 
heat inactivated fetal bovine serum at 37 °C with 5% CO2 in tissue culture flasks.
Details about host proteins and human proteins used in this article are supplied in supplementary materials 
(S10.1).
Enrichment of M. pneumoniae, M. hyopneumoniae and S. aureus surface proteins. Biotinylation. 
Biotinylation of the M. pneumoniae cell surface was carried out as described in67. M. hyopneumoniae and S. aureus 
cells were washed with PBS after centrifugation before the resuspending in EZ-link sulfo-NHS-biotin (Thermo 
Fisher Scientific, North Ryde, Australia). M. hyopneumoniae and S. aureus cells were biotinylated for 30 seconds 
and 1 minute, respectively. Quenching, lysis (for M. hyopneumoniae), avidin purification and western blotting 
were the same as for M. pneumoniae. Lysis for S. aureus cells is described above in section ‘Strains and cultures 
and reagents’.
Triton X-114 phase extraction of biotinylated M. hyopneumoniae proteins. Triton X-114 phase 
extraction of proteins was carried out as described in 77, 83, 137 and biotinylated surface proteins were purified by 
avidin column chromatography.
Trypsin shaving. Trypsin shaving of M. pneumoniae cells was carried out as described previously75 with modifi-
cations. Trypsin was added to adherent M. pneumoniae cells within tissue culture flasks, and M. hyopneumoniae 
and S. aureus cells were resuspended in trypsin.
Preparation and separation of whole cell lysates for one- and two-dimensional gel electropho-
resis. Whole cell lysis preparation. M. pneumoniae and M. hyopneumoniae whole cell lysates were prepared 
as previously described75. Lysis for S. aureus cells is described in section 'Strains and cultures and reagents' above. 
Proteins were reduced and alkylated with 5 mM tributylphosphine and 20 mM acrylamide monomers for 90 min 
at room temperature. Insoluble material was removed by centrifugation and five volumes of acetone added to 
precipitate protein. After centrifugation, the protein pellet was solubilized in 7 M urea, 2 M thiourea, 1% (w/v) 
C7BzO for one- and two-dimensional gel electrophoresis.
1D and 2D SDS-PAGE protein separation. Protein separation was performed as described in79, 82. 80 μg of pro-
tein was separated for 1D SDS-PAGE and 250 μg of protein was cup-loaded for 2D SDS-PAGE separation.
Trypsin Digest. In-gel trypsin digestion was performed as described in77. After digestion, tryptic peptides were 
stored at 4 °C until needed for liquid chromatography tandem mass spectrometry.
Heparin affinity chromatography. Affinity purification of heparin-binding proteins for M. pneumoniae 
was performed as described in67. M. hyopneumoniae cells were and lysed in 10 mM sodium phosphate, pH 7 with 
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three 30 second rounds of sonication. S. aureus cells were lysed as described in section 1.1 except that protein 
was solubilised in 10 mM sodium phosphate, pH 7 with protease inhibitors followed by sonication at maximum 
intensity for 30 seconds for 4 rounds, resting on ice in between. After centrifugation, ~300 µg of soluble protein 
from both M. hyopneumoniae and S. aureus lysates were treated exactly the same as M. pneumoniae.
Avidin purification of host-binding M. pneumoniae proteins. Purified fibronectin (Merck Millipore, 
Darmstadt, Germany), plasminogen (Merck Millipore), actin (Sigma, St. Louis, MO) and fetuin (Sigma) used in 
this section are described in supplementary section S10.1. Avidin purification of these host-binding M. pneumo-
niae proteins was carried out as described in67. Avidin purification of M. pneumoniae proteins that bind A549 
surface proteins was performed as described in67.
Avidin purification of host-binding M. hyopneumoniae proteins. Purified fibronectin (Merck 
Millipore), plasminogen (Sigma) and actin (Sigma) used in this section are described in supplementary section 
S10.1. Avidin purification of these host-binding M. hyopneumoniae proteins was performed as described in84. Avidin 
purification of M. hyopneumoniae proteins that bind PK-15 surface proteins was performed as described in82.
Liquid chromatography tandem mass spectrometry (LC-MS/MS) and MS/MS data analy-
sis. LC-MS/MS was performed as described in82. Mascot (Version 6.1) was used to search MS/MS data files as 
previously described82 with modifications (see supplementary section S10.2 for details).
Expression and purification of rMpnEf-Tu. Expression and purification of rMpnEf-Tu was performed in 
one of two methods as described by100, 88. Details and modifications to methods can be found in supplementary 
materials (section S10.3).
Binding of rMpnEf-Tu to A549 cells. Binding assays. For this experiment and all subsequent experiments, 
animal experiments were approved by the ethical board of Landesdirektion Sachsen, Dresden, Germany (with 
the permit no. permit 24-9168.25-1/2011-1). ELISA experiments were carried out as described in98. Guinea pig 
rMpnEf-Tu antiserum (1:750) followed by anti-guinea pig IgG (1:1,000, Dako, Glostrup, Denmark) dilutions were 
used. Tetramethylbenzidine (Sigma) was added followed by 1 M HCl and absorbance was measured at 450 nm 
(620 nm as reference).
Influence of anti-rMpnEf-Tu on binding. Freshly grown A549 cells were used to coat wells in 96-well microtitre 
plates for 2 h at 37 °C as described in above in ‘Binding assays’. rMpnEf-Tu (10 µg/ml) was incubated with guinea pig 
rMpnEf-Tu antiserum or pre-immune serum (1:100) concentrations were used.
Binding of rMpnEf-Tu to human proteins in ELISA. Purified human proteins used were supplied by Sigma 
and described in supplementary section S10.1. Binding of rMpnEf-Tu (15 µg/ml) to extracellular matrix proteins 
was performed as described previously98. The dilutions for the appropriate antisera are: (Sigma) anti-plasminogen: 
1:2,500; anti-lactoferrin 1:5,000; anti-laminin 1:750; anti-vitronectin 1:5,000; anti-fibrinogen 1:3,000; 
anti-fibronectin 1:1,000. Followed by anti-rabbit IgG (Dako, Glostrup, Denmark) or anti-goat IgG (both 1:2,000).
Microscale thermophoresis. Microscale thermophoresis to determine the binding affinities between Ef-Tu 
and a fluorescently labelled host protein was performed as described in84. Time for Microscale thermophoresis 
was set to 30 s with fluorescence set to 5 s before and 30 s after each run. Each sample was scanned with 40%, 60% 
and 80% MST Power. Dissociation curves were plotted with hot/cold, jump or thermophoresis settings to deter-
mine dissociation constant.
Binding affinity of rMpnEf-Tu to plasminogen. Effect of NaCl on plasminogen-binding. Briefly, 96-well 
microtitre plates were coated with rMpnEf-Tu as described. Plasminogen (2.5 µg) together with increasing con-
centrations of NaCl were added to the wells and incubated for 1.5 h at 37 °C. Wells were incubated with rab-
bit anti-plasminogen (1:3,000) followed by anti-rabbit IgG (1:2,000). Detection was done as described above in 
‘Binding assays’.
Effect of ε-aminocaproic acid on plasminogen-binding. ELISA was carried out as reported in98. In brief, the 
wells of ELISA plates were coated with rMpnEf-Tu. 2.5 µg of plasminogen and increasing concentrations of 
ε-aminocaproic acid were added to the wells and incubated for 1.5 h at 37 °C. Wells were incubated with rabbit 
anti-plasminogen (1:3,000) followed by anti-rabbit IgG (1:2,000) and OD420nm was measured.
Plasminogen activation and degradation of human fibrinogen and vitronectin. Degradation of 
human fibrinogen and vitronectin by activated plasminogen was carried out as described in98. 10 µg/ml of human 
plasminogen was added to the wells which were then incubated with fibrinogen or vitronectin (each 15 µg/ml) 
and urinary plasminogen activator (uPA; Sigma) or tissue plasminogen activator (tPA; each 75 ng/ml; Sigma).
Binding of anti- rMpnEf-Tu antibodies to M. pneumoniae whole cell lysate proteins. Freshly grown 
M. pneumoniae cells were harvested and used to coat wells in 96-well microtitre plate for 2 h at 37 °C as described 
previously100. Wells were blocked before adding guinea pig rMpnEf-Tu antisera (1:500) followed by anti-guinea 
pig IgG (1:1,000). As a control wells were incubated with guinea pig antisera raised against total M. pneumoniae 
proteins.
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Surface localisation of Ef-Tu on M. pneumoniae. Localisation of Ef-Tu on the surface of M. pneumoniae 
colonies. M. pneumoniae colonies were grown on PPLO agar plates and blotted onto nitrocellulose as described 
previously100. Antisera to PdhB and 1-phosphofructokinase (FruK) were used as positive and negative controls, 
respectively.
Surface localisation of Ef-Tu on M. pneumoniae cells. Immunofluorescence experiments were carried out 
as described in100. Again guinea pig antisera to PdhB and FruK were used as positive and negative controls, 
respectively.
Dimethyl labelling and LC-MS/MS analysis of M. pneumoniae, M. hyopneumoniae and S. aureus 
proteins. Dimethyl labelling of proteins. Dimethyl labelling of proteins was performed as described previ-
ously67, 68.
LC-MS/MS of dimethyl labelled proteins. Dimethyl labelled proteins were analysed by two mass spectrometers; 
the Sciex 5600 and the Thermo Scientific Q Exactive™. For full technical set up and method details see supple-
mentary materials (section S10.4).
Bioinformatic analysis of Ef-Tu. Bioinformatic analysis of Ef-Tu used the online resources: ProtParam138, 
Clustal Omega139, SignalP 4.1 Server140, SecretomeP 2.0 Server141, TMpred142 and COILS (Addition of ‘yes’ to 2.5 
fold weighting of positions a,d)143. The amino acid sequences of MpnEf-Tu (Uniprot#: P23568), MhpEf-Tu (Uniprot#: 
Q4A9G1) and SaEf-Tu (Uniprot#: Q2G0N0) were analysed using a variety of bioinformatics tools. Conservation 
of amino acid positions in each protein were detected using The ConSurf server96. Putative heparin-binding 
sites were identified using the search patterns X-[HKR]-X(0,2)-[HKR]-X(0,2)-[HKR]-X and X-[HKR]-X(1,4)-
[HKR]-X(1,4)-[HKR]-X via ScanProsite144. Putative protein-protein and protein-nucleic acid interaction sites 
were identified using ISIS95. Intrinsically disordered regions were predicted by Meta-Disorder145, 146, which 
combines the outputs from original prediction methods NORSnet, DISOPRED2, PROFbval and Ucon. Solvent 
accessibility of each amino acid position was ascertained using evolutionary information from multiple sequence 
alignments and a multi-level system147. Nucleotide, DNA and RNA binding regions were predicted by SomeNA148.
Data availability statement. The datasets generated during and/or analysed during the current study are 
available from the corresponding author on reasonable request.
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